Cochlear Ltd logo

Cochlear Ltd

1
ASX:COH (Australia)   Ordinary Shares
A$ 330.39 (-2.51%) May 17
62.09
P/B:
12.18
Market Cap:
A$ 21.64B ($ 14.50B)
Enterprise V:
A$ 21.36B ($ 14.32B)
Volume:
98.11K
Avg Vol (2M):
111.15K
Also Trade In:
Volume:
98.11K
Avg Vol (2M):
111.15K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Cochlear Ltd ( ASX:COH ) from 1995 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cochlear stock (ASX:COH) PE ratio as of May 20 2024 is 62.09. More Details

Cochlear Ltd (ASX:COH) PE Ratio (TTM) Chart

To

Cochlear Ltd (ASX:COH) PE Ratio (TTM) Historical Data

Total 1271
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Cochlear PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-20 62.1 2024-03-18 62.5
2024-05-17 62.1 2024-03-15 62.6
2024-05-16 63.7 2024-03-14 63.2
2024-05-15 62.4 2024-03-13 62.5
2024-05-14 61.2 2024-03-12 62.7
2024-05-13 61.1 2024-03-11 63.1
2024-05-10 60.2 2024-03-08 64.3
2024-05-09 60.6 2024-03-07 63.1
2024-05-08 61.9 2024-03-06 63.5
2024-05-07 61.6 2024-03-05 63.0
2024-05-06 60.9 2024-03-04 63.4
2024-05-03 60.3 2024-03-01 63.2
2024-05-02 59.4 2024-02-29 65.8
2024-05-01 59.6 2024-02-28 64.8
2024-04-30 61.1 2024-02-27 64.4
2024-04-29 60.9 2024-02-26 65.0
2024-04-26 60.3 2024-02-23 64.6
2024-04-25 60.1 2024-02-22 64.0
2024-04-24 60.1 2024-02-21 64.1
2024-04-23 60.7 2024-02-20 62.1
2024-04-22 60.7 2024-02-19 61.6
2024-04-19 59.3 2024-02-16 62.9
2024-04-18 59.9 2024-02-15 62.2
2024-04-17 59.8 2024-02-14 61.8
2024-04-16 59.2 2024-02-13 61.0
2024-04-15 59.8 2024-02-12 60.5
2024-04-12 60.1 2024-02-09 60.6
2024-04-11 60.3 2024-02-08 57.3
2024-04-10 60.0 2024-02-07 54.8
2024-04-09 60.0 2024-02-06 54.0
2024-04-08 61.3 2024-02-05 58.0
2024-04-05 61.4 2024-02-02 58.1
2024-04-04 62.7 2024-02-01 57.3
2024-04-03 62.0 2024-01-31 57.2
2024-04-02 63.2 2024-01-30 56.6
2024-04-01 63.4 2024-01-29 56.8
2024-03-29 63.4 2024-01-26 56.3
2024-03-28 63.4 2024-01-25 56.3
2024-03-27 63.3 2024-01-24 56.0
2024-03-26 63.0 2024-01-23 56.8
2024-03-25 63.4 2024-01-22 56.2
2024-03-22 62.4 2024-01-19 56.1
2024-03-21 61.8 2024-01-18 54.4
2024-03-20 62.0 2024-01-17 54.2
2024-03-19 62.0 2024-01-16 53.6

Cochlear Ltd (ASX:COH) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.